$CURA

TerrAscend Corp. reported stronger-than-expected earnings for Q4 2025, driven by increased sales across its cannabis product lines. The company has expanded its market presence, capturing significant market share in the Northeastern US. Despite some ongoing regulatory challenges, management remains optimistic about future growth prospects. Investors reacted positively to the earnings call, with stock prices trending upward post-announcement. Overall, the results reflect a solid operational performance and a positive outlook for the cannabis sector.